Subscribe to the Voices in Health Care Value newsletter to be notified about new research, policies, and upcoming events relevant to the health care value community.
Welcome to the seventh issue of Voices in Health Care Value, the newsletter of the Research Consortium for Health Care Value Assessment (RC-HCVA). This issue features work from our colleagues at the Healthcare Value Hub. We appreciate your comments and inputs to subsequent issues. If you are interested in becoming a Colleague in Value (individuals and groups who work in this area or who are simply interested in its findings) please register here.
By George Miller
This quarter’s featured Colleague in Value is Altarum’s own Healthcare Value Hub. (A summary of the work of the Hub appears later in this newsletter.) Some of the Hub’s activities complement those of the Research Consortium for Health Care Value Assessment (RC-HCVA) that are aimed at identifying and addressing low-value care.
Both the Hub and the RC-HCVA have recently conducted analyses to identify differences among states in controlling low-value care. One of the features of the Hub’s Healthcare Affordability State Policy Scorecard is an assessment of states’ progress in reducing the provision of low- and no-value care with respect to both policies and outcomes. Similarly, a recent study conducted by the RC-HCVA estimated the frequency of each state’s provision of low-value care to commercially-insured beneficiaries for 20 specific clinical services. Each of these analyses revealed significant differences in the degree to which different states are addressing wasteful clinical spending. A discussion of the results of the two studies is included in our most recent RC-HCVA concept paper, written by the Hub’s Lynn Quincy and Amanda Hunt. An earlier RC-HCVA concept paper discusses the value of such state-level assessments. While assessments at the state level mask differences in local practice patterns that help explain state-to-state differences, they do provide state policy makers with evidence that can provide incentives to address low-value care at the state level.1
The need for such state-level action has never been more evident. The COVID-19 pandemic has highlighted our nation’s current underfunding of public health and bio-threat preparedness, as well as the important role states play in such preparations. Furthermore, as more of our limited health care resources are diverted to addressing the pandemic, fewer resources are available for other clinical needs. In the long run, reducing low-value care will help free up funds to more efficiently address ongoing clinical, public health, and bio-threat needs, helping us to prepare for the next health care crisis.
1. Other researchers have addressed aspects of low-value care at a more granular geographic level. See, for example, the work of Colla and colleagues (2014) and Oakes and colleagues (2020).
The second Quick Strike project from the Research Consortium for Health Care Value Assessment was published, looking at state level estimates of selected low-value care services. Read here.
This article by Maria Castelluci from Modern Healthcare highlights findings from the Consortium’s Quick Strike 2 project. Read article here.
Other articles highlighting findings from the Consortium’s Quick Strike 2 project.
A demonstration brief was published by the Research Consortium on using the Low Value Care Visualizer to find meaning within dense claims data. Read here.
Academy Health discusses the Low Value Care Visualizer, a new resource provided by the Research Consortium for Health Care Value Assessment. Read here.
In an article by Henderson and colleagues published in JAMA Internal Medicine, research findings suggest that Vitamin D tests reduced significantly in Canada when tied to non-payment policies, compared to a slight reduction from information initiatives such as Choosing Wisely. Read article here.
Read commentary on Henderson’s work by Dr. Eve Kerr from IHI here.
In an article by Allison Oakes and colleagues published in Medical Care, research findings suggest that systematic overuse associated with observable, structural characteristics of the regional health care system. Read here.
Each issue will spotlight work by a Colleague in Value. This issue’s spotlight is on Altarum's Healthcare Value Hub.
The Healthcare Value Hub
With support from the Robert Wood Johnson Foundation, the Healthcare Value Hub provides free, timely information about the policies and practices needed to achieve an equitable and affordable health system that focuses on the goals and needs of the people it serves.
The Hub works at the intersection of advocacy, research and policy, with a staff dedicated to monitoring, translating and disseminating evidence, and a focus on connecting advocates, researchers and policymakers to build communities and create momentum toward a patient-centered, high-value healthcare system.
Our evidence reviews focus on:
Resources
The Hub’s FREE, publicly available resources include:
Connect with the Hub:
The Hub connects advocates, researchers and policymakers together to further conversations and action to improve quality, increase equity and lower the cost of healthcare. Go to www.HealthcareValueHub.org/Stay-Connected to sign up for:
Sign up for Voices in Health Care Value
The Research Consortium for Health Care Value Assessment is a partnership with VBID Health, with funding from the PhRMA Foundation as part of its Value Assessment Initiative, established to promote the pursuit of value in health care delivery in the U.S. Follow us at @ValueConsortium.